Online citations, reference lists, and bibliographies.
← Back to Search

The Applicability Of A Cluster Of Differentiation Monoclonal Antibody Microarray To The Diagnosis Of Human Disease.

P. Ellmark, A. Woolfson, L. Belov, R. Christopherson
Published 2008 · Medicine, Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Recent advances in antibody microarray technology have facilitated the development of multiplexed diagnostic platforms. Highly parallel antigen expression data obtained from these arrays allow disease states to be characterized using protein patterns rather than individual protein markers. The development of an antibody microarray platform of general applicability requires careful consideration of the array content. The human cluster of differentiation (CD) antigens constitute a promising candidate set, being united by their common expression at the leukocyte cell surface and the fact that the majority perform critical functions in the human immune response. The diagnostic potential of a microarray, containing 82 cluster of differentiation monoclonal antibodies (DotScan microarrays) has been demonstrated for a variety of infectious and neoplastic disease states, including HIV, many acute and chronic leukemias, and colorectal cancer. It is likely that these microarrays will have more general utility that extends to other pathological categories, including autoimmune, metabolic, and degenerative diseases.
This paper references
10.2217/14622416.7.5.759
The application of CD antigen proteomics to pharmacogenomics.
A. Woolfson (2006)
Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
L. Belov (2001)
10.1002/PMIC.200500468
Multiplex detection of surface molecules on colorectal cancers
Peter Ellmark (2006)
10.1186/gb-2001-2-2-research0004
Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions
B. Haab (2000)
10.1517/14712598.6.8.833
Antibody microarray-based oncoproteomics
C. Borrebaeck (2006)
Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies.
J. Louhimo (2002)
10.1182/BLOOD-2004-12-4642
Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individuals.
A. Woolfson (2005)
10.1126/SCIENCE.289.5485.1760
Printing proteins as microarrays for high-throughput function determination.
G. MacBeath (2000)
10.1038/nri1837
Potent antibody therapeutics by design
P. Carter (2006)
10.1016/S1359-6446(02)02413-3
Antibody arrays: an embryonic but rapidly growing technology.
S. Lal (2002)
10.1158/0008-5472.CAN-05-1436
Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer.
R. Orchekowski (2005)
10.1002/PMIC.200390009
Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers
J. Miller (2003)
10.1074/mcp.M600170-MCP200
Identification of Protein Expression Signatures Associated with Helicobacter pylori Infection and Gastric Adenocarcinoma Using Recombinant Antibody Microarrays*
P. Ellmark (2006)
10.1111/j.1365-2141.2006.06266.x
Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray
L. Belov (2006)
10.1002/1615-9861(200110)1:10<1271::AID-PROT1271>3.0.CO;2-6
Proteomic profiling of the cancer microenvironment by antibody arrays
V. Knezevic (2001)
10.1007/s10620-006-3135-x
The Combined Elevation of Tumor Markers CA 19-9 and CA 125 in Liver Disease Patients Is Highly Specific for Severe Liver Fibrosis
M. Schöniger-Hekele (2006)
10.1002/PMIC.200300599
Identification of repertoires of surface antigens on leukemias using an antibody microarray
L. Belov (2003)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar